InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: MelsDollars post# 160466

Wednesday, 04/21/2021 12:36:20 PM

Wednesday, April 21, 2021 12:36:20 PM

Post# of 233221

I doubt the entire company is up for sale. It's just too valuable with so many potential indications. However, I wouldn't be surprised if a licensing or partnership deal was structured for one indication, covid-19 in the U.S. for example. That would bring an infusion of cash and allow them to ramp up future trials.


Selling the rights to Covid would make sense. It would allow them to concentrate on Cancer and HIV which are far slower trials. But most of CYDY's market cap comes from Covid and no one is going to pay even a $1 billion for those rights. CYDY is valued far too high for any buyout of any kind to happen.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News